There are 383 resources available
192P - Randomized, phase II, placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis
Presenter: Zachary Moore
Session: Poster Display session
193P - Safety and efficacy of immmunotherapy rechallenge following a previous immune-induced interstial lung disease
Presenter: Célia Joseph
Session: Poster Display session
194P - Modelling strategies to combine multiple serum tumor biomarkers for early prediction of immunotherapy non-response in non-small cell lung cancer.
Presenter: Freek van Delft
Session: Poster Display session
195P - Radiomics and dosiomics signature from whole lung predicts radiation pneumonitis : A model development study with prospective external validation and decision-curve analysis
Presenter: Zhen Zhang
Session: Poster Display session
196P - An international consensus on actions to improve lung cancer survival: A clinical review by the international cancer benchmarking partnership (ICBP)
Presenter: Charlotte Lynch
Session: Poster Display session
197P - Lung cancer in lung transplant recipients
Presenter: Monika Svorcova
Session: Poster Display session
198P - Association between BTLA polymorphisms and NSCLC risk
Presenter: Anna Andrzejczak
Session: Poster Display session
199P - The relative impact of surgery history on cancer risk in patients less than 60 years old
Presenter: Haixuan Wang
Session: Poster Display session
200P - The value of holistic assessment and rapid intervention: The lung cancer outpatient occupational therapy service (LCOOTS)
Presenter: Jenny Welford
Session: Poster Display session
201P - Readability of thoracic surgery consent forms in Queensland, Australia
Presenter: Sanjay Dutta
Session: Poster Display session